FDA Drug Recalls

Recalls / Class II

Class IID-1434-2012

Product

Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05

Brand name
Amlodipine Besylate And Benazepril Hydrochloride
Generic name
Amlodipine Besylate And Benazepril Hydrochloride
Active ingredients
Amlodipine Besylate, Benazepril Hydrochloride
Route
Oral
NDCs
55111-338, 55111-339, 55111-340, 55111-341
FDA application
ANDA077183
Affected lot / code info
C201293 Exp Date 08/2013

Why it was recalled

Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr.Reddy's Laboratories Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
200 Somerset Corporate Blvd Fl 7th, N/A, Bridgewater, New Jersey 08807-2862

Distribution

Quantity
1656 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2012-04-09
FDA classified
2012-07-31
Posted by FDA
2012-08-08
Terminated
2013-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1434-2012. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Amlodipine Besylate And Benazepril Hydrochloride · FDA Drug Recalls